These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7626455)

  • 21. Hormone replacement therapy and estrogen-dependent cancers.
    Birkhäuser M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study.
    Vestergaard P; Hermann AP; Stilgren L; Tofteng CL; Sørensen OH; Eiken P; Nielsen SP; Mosekilde L
    Maturitas; 2003 Oct; 46(2):123-32. PubMed ID: 14559383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
    Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy and cancer risk.
    Mahavni V; Sood AK
    Curr Opin Oncol; 2001 Sep; 13(5):384-9. PubMed ID: 11555717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geriatric gynaecology.
    Cheang A; Kottegoda SR; Ratnam SS
    Ann Acad Med Singap; 1987 Jan; 16(1):66-73. PubMed ID: 3296937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
    Rozenberg S
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):86-91. PubMed ID: 11134831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk.
    Mourits MJ; DE Bock GH
    Int J Gynecol Cancer; 2006; 16 Suppl 2():494-6. PubMed ID: 17010054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk assessment of the menopausal patient.
    Kothari S; Thacker HL
    Med Clin North Am; 1999 Nov; 83(6):1489-502. PubMed ID: 10584604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy and endometrial cancer].
    Araújo NL; Athanazio DA
    Cad Saude Publica; 2007 Nov; 23(11):2613-22. PubMed ID: 17952254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progestins in the menopause.
    Sitruk-Ware R
    J Steroid Biochem Mol Biol; 1999; 69(1-6):185-93. PubMed ID: 10418992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.